This profesional development course delves deep into the world of abnormal plasma cells, exploring their role in our immune system and the creation of monoclonal proteins, or M-proteins. Understand the increasing prevalence of this condition and its correlation with an aging population and advances in therapeutic strategies.
Upon completion of this course, you will be able to:
- Identify the common signs and symptoms of multiple myeloma.
- Assess patients with signs and symptoms suggestive of multiple myeloma.
- Initiate referral as needed based on relevant information gathered from the initial multiple myeloma work-up.
- Discuss the monitoring and management of symptoms of diagnosed multiple myeloma or precursor conditions.
Dr. Bethany Monteith, Division of Hematology, Queen’s University
Dr. Alison White, Family Physician, Alberta
Dr. Ann Lee, Family Physician, Alberta
Dr. Genevieve Chaput, McGill University Health Centre
Dr. Julie Stakiw, Medical Director, Oncology & Clinical Professor Hematological Oncology, University of Saskatchewan
In this module, you will be reviewing the signs, diagnosis, and treatment of multiple myeloma.
This self-assessment program is an effort to mobilize these approaches to primary care and interprofessional teams to help fulfill the promise of these treatments.
This online program is accredited by Queen’s University for 1.5 Self-Assessment learning hours for the Royal College, 1.5 Mainpro+ Credits in the Self-Learning Category for the CFPC, and provides a certificate for 1.5 hours of professional development for all health professions.
For a limited time, enrollment for this course is complimentary for one year of access.
Please note that the free enrollment seats are limited and will be allocated on a first-come, first-served basis. Once the free seats are filled, interested learners can still join the course by paying the specified fee. Course fees (when applicable) are non-refundable.
